TITLE

Elevated γ-glutamyltransferase in implantable cardioverter defibrillator patients

AUTHOR(S)
Dichtl, Wolfgang; Wolber, Thomas; Paoli, Ursula; Theurl, Thomas; Brüllmann, Simon; Stühlinger, Markus; Berger, Thomas; Spuller, Karin; Strasak, Alexander; Pachinger, Otmar; Haegeli, Laurent; Duru, Firat; Hintringer, Florian
PUB. DATE
January 2012
SOURCE
Wiener Klinische Wochenschrift;Jan2012, Vol. 124 Issue 1/2, p18
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
BACKGROUND: Elevated γ-glutamyltransferase (GGT) is a new risk factor for cardiovascular diseases, but its impact on ventricular tachyarrhythmia occurrence and survival in patients with an implantable cardioverter defibrillator (ICD) is unknown. METHODS AND RESULTS: Considering that GGT levels are gender-dependent, female ICD recipients were excluded from our database because of the low incidence of events. In a retrospective analysis, appropriate ICD therapy (both shocks and antitachycardia pacing due to ventricular tachyarrhythmias) occurred in 31.9% of 320 male patients who had received an ICD for primary prevention (median follow-up of 2.3 years), and in 55.1% of 423 male patients who had received an ICD for secondary prevention (median follow-up of 3.9 years). Compared to normal low GGT plasma levels (below 28 U/L), total mortality but not risk for appropriate ICD therapy was elevated for higher GGT categories ( p for trend = 0.004 in primary prevention and p for trend = 0.002 in secondary prevention, respectively). In Cox regression analysis, elevated GGT (>56 U/L) remained an independent predictor of death both in primary ( p = 0.011) and in secondary prevention ( p = 0.006). Patients with elevated GGT and renal insufficiency defined by an estimated glomerular filtration rate <60 ml/min/1.73 m suffered from excess total mortality jeopardizing the benefit of ICD therapy. CONCLUSION: Elevation of GGT is an important adverse prognostic parameter in ICD patients. A possible role of GGT for improved patient selection for ICD therapy deserves further investigation.
ACCESSION #
71284803

 

Related Articles

  • Electrical Storms in Patients with an Implantable Cardioverter Defibrillator.  // Yonsei Medical Journal;1/1/2011, Vol. 52 Issue 1, p26 

    No abstract available.

  • Automatic Implantable Cardioverter Defibrillator. Manolis, Antonis S.; Rastegar, Hassan; Estes III, A. Mark // JAMA: Journal of the American Medical Association;9/8/89, Vol. 262 Issue 10, p1362 

    Discusses the development of the automatic implantable cardioverter defibrillator (ACID). Design of the apparatus to detect and terminate ventricular tachycardia (VT) or fibrillation (VF); Evolution from an investigation to a clinical tool for management of malignant ventricular arrhythmias;...

  • Initial Experience with Wearable Cardioverter-Defibrillator. DiMarco, John P. // Clinical Cardiology Alert;Sep2010, Vol. 29 Issue 9, p69 

    THE WEARABLE CARDIOVERTER-DEFIBRILLATOR (WCD) IS A totally external system that can monitor a patient's cardiac rhythm and automatically treat episodes of ventricular tachycardia (VT) and ventricular fibrillation (VF) when they are detected. The WCD was market released in the United States in...

  • When can survivors of ventricular arrhythmias resume driving?  // Modern Medicine;Dec94, Vol. 62 Issue 12, p56 

    Presents an abstract of the report titled `Recurrent cardiac events in survivors of ventricular fibrillation or tachycardia: Implications for driving restrictions,' by G.C. Larsen, M.R. Stupey, et al, published in the May 4, 1994 issue of `Journal of American Medical Association.'

  • A 2-Tiered Approach to In-Hospital Defibrillation Nurses Respond to a Trial of Using Automated External Defibrillators as Part of a Code-Team Protocol. Kyller, Michael; Johnstone, Donald // Critical Care Nurse;Aug2005, Vol. 25 Issue 4, p25 

    This article discusses the initiation of a 2-tiered defibrillation response in order to identify the importance of early defibrillation in cardiac arrest and describe its limitation. A survey was completed at Boston Medical Center to gather data on the attitudes of nurses in non-critical care...

  • Inappropriate ICD shocks. Graf, Denis; Pruvot, Etienne // Heart;Dec2007, Vol. 93 Issue 12, p1532 

    The article focuses on the inappropriate shocks caused by the implantable cardioverter-defibrillator (ICD) for episodes of ventricular tachycardia. Several experts show that the high frequency discharges of increasing amplitude are seen before shock delivery. Meanwhile, tracing was found...

  • Sumatriptan.  // Reactions Weekly;May2015, Vol. 1550 Issue 1, p190 

    The article presents a case study of a 42-year-old woman who developed ventricular fibrillation (VF) arrest subsequently to torsades de pointes (polymorphic ventricular tachycardia) following administration of sumatriptan, which was published in a 2014 issue of the journal "Current Drug Safety."

  • Initial Experience with Wearable Cardioverter-Defibrillator. DiMarco, John P. // Clinical Cardiology Alert;Sep2010 Pharmacology, p69 

    THE WEARABLE CARDIOVERTER-DEFIBRILLATOR (WCD) IS A totally external system that can monitor a patient's cardiac rhythm and automatically treat episodes of ventricular tachycardia (VT) and ventricular fibrillation (VF) when they are detected. The WCD was market released in the United States in...

  • Driving and ICD Shocks for Ventricular Arrhythmias. DiMarco, John P. // Clinical Cardiology Alert;Jan2008, Vol. 27 Issue 1, p6 

    The triggers of ventricular arrhythmia (tova Study) was a multicenter, prospective, cohort study that examined lifestyle and psychological triggers that might result in implantable cardioverterdefibrillator (ICD) shocks for ventricular tachycardia (VT) or ventricular fibrillation (VF). The study...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics